Monday, November 21, 2011

Pharmacy Acquisitions and Florida EBITDA

By Brad MacLiver
Authorship and profile at Google


EBITDA is an acronym which means: Earnings Before Interest, Taxes, Depreciation and Amortization.  EBITDA is often used to measure the value of some businesses and in the comparison of similar companies.

EBITDA typically makes it easier to evaluate various companies and to compare them against industry averages by removing the non-core and irregular operating costs like as interest (which can vary depending on the management’s choice of financing), taxes (which can fluctuate depending on acquisitions or losses from prior years), and arbitrary factors of depreciation and amortization.

The formula for EBITDA can be seen as a guideline when valuing larger companies or when comparing the profitability of large similar companies in the same industry.

For the effective use of EBITDA, these larger companies should possess significant assets, have heavy amortization schedules, or bear substantial amounts of debt. Considering independent pharmacies don’t meet that criteria, this formula is not a useful measure as the sole means for valuing Florida pharmacies for acquisition purposes.

Here is what needs to be calculated for EBITDA: 1. Net income can be calculated by obtaining total income and subtract total expenses.
2. Total amount of taxes paid to federal, state, and local governments.
3. Interest fees paid to companies or individuals for the use of credit, or capital.
4. Cost of depreciation, or the expense recorded to allocate a tangible asset's cost over its useful life.
5. Cost of amortization, or the expense for consumption of the value of intangible assets (such as goodwill, patents, and copyrights) over a the asset's expected life or specific period of time.

Finally, add steps #1 through #5.

EBITDA calculation example:

1. Net Income            1,070
2. + Taxes paid            308
3. + Interest Expenses     210
4. + Depreciation          104
5. + Amortization           52
6. = EBITDA              1,744

Drawbacks of EBITDA: 1. Can be misleading number when it is confused with cash flow.
2. Can make even completely unprofitable firms appear to be financially healthy.
3. Numbers are easy to manipulate.
4. Can overlook cash requirements for growth in accounts receivable.
5. Can miss cash requirements for growth in inventories.
6. Not factual when valuing small companies.
7. Not effective for companies with few assets, small amounts of debt, or low depreciation or amortization schedules.

During the 1980s EBITDA was being used as a proxy for cash flow in leveraged buyouts to calculate whether companies could service their debt. Factoring out interest, taxes, depreciation, and amortization can allow an unprofitable business to appear financially healthy. This method of valuation was used extensively during the dotcom era to value unprofitable businesses, with few assets, little earnings, and the results from that method caused many to go bust. This was a blaring example of misapplying EBITDA.

Pharmacy specialists who are knowledgeable and performing pharmacy business valuations in FL will use EBITDA in pharmacy valuations, but this will only be a part of a larger formula when computing values for specialty Florida pharmacies especially those who have a niche in HIV, disease management, long term care, etc. However, EBITDA should not be used as part of the usual formula for standard retail pharmacy acquisitions.

The EBITDA number for a specific existing pharmacy in FL is, for the most part, important when the existing ownership is establishing their store value for the purposes of a credit line, borrowing, creating a Trust, stock values, etc., but EBITDA does not have the same importance when selling a Florida pharmacy. This is due to the fact the buyer will not have the same expenses as the seller.

Buyers may not have the same tax base, interest expense, or the same depreciation schedule. It is thusly important that the buyer estimate an EBITDA that is specific to their operating model, business systems, buying power, cost of operations, etc., not the sellers. It should also be noted that EBITDA assumes that the buyer will acquire all of the assets, working capital, accounts receivable, and liabilities. Those assumptions do not hold true regarding an acquisition of a pharmacy. Instead of the EBITDA number, Florida pharmacy buyers should be focusing on sales, gross profit, cash flow, and customer mix.

************************